You are here: Industry Insights > Acquisition

News List

SOTIO acquires Cytune Pharma biospectrumasia
September 03, 2018
All Cytune projects will be developed as part of SOTIO’s pipeline.
China Biologic announces updates on unsolicited acquisition proposals biospectrumasia
August 28, 2018
After careful review of the Consortium's proposal, the Board has unanimously determined that it is not in the best interests of the Company and its shareholders
DexCom acquires TypeZero Tech biospectrumasia
August 24, 2018
DexCom expects to launch the first automated insulin delivery system using TypeZero's InControl algorithm in 2019.
Star Combo Pharma acquires Ausway Group of Companies biospectrumasia
August 13, 2018
Ausway specialises in the supply and distribution of vitamins and dietary supplements both in Australia and overseas with a particular emphasis on its e-commerce platform which sells directly into China
Astellas acquires Quethera for up to £85M biospectrumasia
August 13, 2018
Through this transaction, Astellas has acquired Quethera's ophthalmic gene therapy program, which uses a recombinant adeno-associated viral vector system (rAAV) to introduce therapeutic genes into target retinal cells for the treatment of glaucoma.
Varian acquires HumediQ Global GMbH biospectrumasia
August 08, 2018
This acquisition expands Varian's motion-management portfolio and is part of the company's long-term growth and value creation strategy.
Takeda closes TiGenix acquisition for about $608m pharmaceutical-technology
August 03, 2018
Takeda Pharmaceutical has completed its purchase of all outstanding ordinary shares of Belgium-based TiGenix for approximately $608.84m (€520m), representing €1.78 per share.
Cipla to acquire South African drug firm for $33M biospectrumasia
July 16, 2018
The drugmaker will acquire Mirren through wholly owned unit Cipla Medpro South Africa.
Eli Lilly closes $1.6bn ARMO BioSciences acquisition pharmaceutical-technology
June 28, 2018
Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn.
Bio-Techne to acquire Exosome Diagnostics biospectrumasia
June 27, 2018
The transaction will be financed through a combination of cash on hand and a revolving line of credit facility that Bio-Techne expects to obtain prior to the closing of the acquisition.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page